IL-15 drives neonatal T cells to acquire CD56 and become activated effector cells

Blood. 2003 Sep 15;102(6):2195-7. doi: 10.1182/blood-2003-01-0232. Epub 2003 May 22.

Abstract

Expression of one or more natural killer (NK) receptors on T cells may correlate with effector function. This study investigated the frequency of neonatal NK receptor-positive (NKR+) T cells and their expansionary properties with interleukin-2 (IL-2), IL-7, or IL-15. While cord blood contains significantly decreased frequencies of NKR+ T cells compared with adult blood, newborn CD56+CD3+ cells could be expanded 200-fold during culture with IL-15. By depleting CD56+ cells, we were able to determine that this expansion was due to a subpopulation of T cells acquiring CD56 expression. Moreover, CD56 acquisition was associated with a distinct CD8+CD25+ interferon gamma-positive (IFN-gamma+) phenotype. This property could therefore be exploited during bone marrow reconstitution and may partially account for the resilience of the newborn to infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • CD56 Antigen / metabolism*
  • Cells, Cultured
  • Fetal Blood / cytology
  • Humans
  • Immune System / cytology
  • Immune System / growth & development*
  • Immune System / immunology
  • Infant, Newborn
  • Interleukin-15 / metabolism*
  • Killer Cells, Natural / cytology
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism
  • T-Lymphocytes / cytology
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / metabolism*

Substances

  • CD56 Antigen
  • Interleukin-15